By Ruth Whittington (ruth.whittington@rxcomms.com) Part 4 – Interpreting the results of observational studies In the last of our series on observational studies, this article addresses some of the issues involved…
DetailsBy Mary Gabb (mary.gabb@rxcomms.com) Billions of emails are sent each day round the world. What most people don’t realise, however, is that email is like a postcard; it can be…
DetailsBy Clare Gurton (clare.gurton@rxcomms.com) Somewhere inside all of us is the desire to be ‘good’ and to be liked. And, as a result, we may find we shy away from…
DetailsBy Jonathan Coopersmith (jonathan.coopersmith@rxcomms.com) Benjamin Franklin said “An ounce of prevention is worth a pound of cure”. Perhaps the best way to reduce errors in medicine, then, is to prevent…
DetailsBy Clare Gurton (clare.gurton@rxcomms.com) There is an increasing need for all of us to develop strategies for dealing with different cultures as business becomes more international and cross communication among…
DetailsBy Ruth Whittington (ruth.whittington@rxcomms.com) Part 3 – Conducting an observational study Last month, we looked at the differences between observational studies and randomised controlled trials (RCTs). Here, we look at…
DetailsBy David Woods (david.woods@rxcomms.com) Question: “How many people work in the public sector?” Answer: “About half of them.” It’s an old one, to be sure, but it has its echo…
DetailsBy David Woods (david.woods@rxcomms.com) If you feel that emails are inundating you, and you yearn for the days of the quill pen, help is at hand. In her recent book…
DetailsBy Amy Rothman Schonfeld (amy.schonfeld@rxcomms.com) One year after its first conference, the American Society of Health Economists (ASHE) is clearly thriving. Its membership has grown to more than 800, planning…
DetailsBy David Woods (david.woods@rxcomms.com) The theme of this year’s international ISPOR meeting – held on May 20–23 in Arlington, Virginia, USA – was “new tools, new audiences for health outcomes…
Details
